{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:22:24Z","timestamp":1789986144985,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":5747,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1177\/1087057106288048","type":"journal-article","created":{"date-parts":[[2006,8,23]],"date-time":"2006-08-23T17:03:03Z","timestamp":1156352583000},"page":"457-468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Phenotype-Based Screening of Mechanistically Annotated Compounds in Combination with Gene Expression and Pathway Analysis Identifies Candidate Drug Targets in a Human Squamous Carcinoma Cell Model"],"prefix":"10.1016","volume":"11","author":[{"given":"M\u00e5rten","family":"Frykn\u00e4s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Rickardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Wickstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeer","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"L\u00f6vborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Gullbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nygren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats G.","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Isaksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1177\/1087057106288048_bib1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/02841860151116204","article-title":"What is cancer chemotherapy?","volume":"40","author":"Nygren","year":"2001","journal-title":"Acta Oncol"},{"key":"10.1177\/1087057106288048_bib2","first-page":"487","article-title":"High-throughput screening-driven lead discovery: meeting the challenges of finding new therapeutics.","volume":"8","author":"Posner","year":"2005","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1177\/1087057106288048_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1359-6446(05)03415-X","article-title":"Finding the target after screening the phenotype.","volume":"10","author":"Hart","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1177\/1087057106288048_bib4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.chembiol.2003.08.009","article-title":"Biological mechanism profiling using an annotated compound library.","volume":"10","author":"Root","year":"2003","journal-title":"Chem Biol"},{"key":"10.1177\/1087057106288048_bib5","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.chembiol.2004.08.026","article-title":"A flexible data analysis tool for chemical genetic screens.","volume":"11","author":"Kelley","year":"2004","journal-title":"Chem Biol"},{"key":"10.1177\/1087057106288048_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/73439","article-title":"A gene expression database for the molecular pharmacology of cancer.","volume":"24","author":"Scherf","year":"2000","journal-title":"Nat Genet"},{"key":"10.1177\/1087057106288048_bib7","first-page":"1139","article-title":"An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines.","volume":"62","author":"Dan","year":"2002","journal-title":"Cancer Res"},{"key":"10.1177\/1087057106288048_bib8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.bjc.6602699","article-title":"Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles.","volume":"93","author":"Rickardson","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1177\/1087057106288048_bib9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/bjc.1996.453","article-title":"Anticancer drug characterisation using a human cell line panel representing defined types of drug resistance.","volume":"74","author":"Dhar","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1177\/1087057106288048_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00001813-200401000-00008","article-title":"Development and characterization of two human tumor sublines expressing high-grade resistance to the cyanoguanidine CHS 828.","volume":"15","author":"Gullbo","year":"2004","journal-title":"Anticancer Drugs"},{"key":"10.1177\/1087057106288048_bib11","first-page":"5125","article-title":"Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein.","volume":"46","author":"Dalton","year":"1986","journal-title":"Cancer Res"},{"key":"10.1177\/1087057106288048_bib12","first-page":"995","article-title":"Development and characterization of a melphalan-resistant human multiple myeloma cell line.","volume":"51","author":"Bellamy","year":"1991","journal-title":"Cancer Res"},{"key":"10.1177\/1087057106288048_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00686114","article-title":"Up-regulation of gamma-glutamylcysteine synthetase activity in melphalan-resistant human multiple myeloma cells expressing increased glutathione levels.","volume":"34","author":"Mulcahy","year":"1994","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1177\/1087057106288048_bib14","first-page":"7900","article-title":"Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model.","volume":"63","author":"Hazlehurst","year":"2003","journal-title":"Cancer Res"},{"key":"10.1177\/1087057106288048_bib15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ijc.2910580221","article-title":"Development of vincristine resistance and increased sensitivity to cyclosporin A and verapamil in the human U-937 lymphoma cell line without overexpression of the 170-kDa P-glycoprotein.","volume":"58","author":"Botling","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1177\/1087057106288048_bib16","first-page":"2594","article-title":"Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.","volume":"47","author":"Mirski","year":"1987","journal-title":"Cancer Res"},{"key":"10.1177\/1087057106288048_bib17","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1360704","article-title":"Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.","volume":"258","author":"Cole","year":"1992","journal-title":"Science"},{"key":"10.1177\/1087057106288048_bib18","first-page":"3221","article-title":"Localization of a novel multidrug resistance-associated gene in the HT1080\/DR4 and H69AR human tumor cell lines.","volume":"53","author":"Slovak","year":"1993","journal-title":"Cancer Res"},{"key":"10.1177\/1087057106288048_bib19","first-page":"1297","article-title":"Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26).","volume":"47","author":"Danks","year":"1987","journal-title":"Cancer Res"},{"key":"10.1177\/1087057106288048_bib20","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1021\/bi00424a026","article-title":"Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26.","volume":"27","author":"Danks","year":"1988","journal-title":"Biochemistry"},{"key":"10.1177\/1087057106288048_bib21","doi-asserted-by":"crossref","first-page":"10793","DOI":"10.1021\/bi9909804","article-title":"Mutations of human topoisomerase II alpha affecting multidrug resistance and sensitivity.","volume":"38","author":"Mao","year":"1999","journal-title":"Biochemistry"},{"key":"10.1177\/1087057106288048_bib22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1158\/1535-7163.521.3.5","article-title":"Multiparametric evaluation of apoptosis: effects of standard cytotoxic agents and the cyanoguanidine CHS 828.","volume":"3","author":"Lovborg","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1177\/1087057106288048_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.devbrainres.2003.10.001","article-title":"Spatiotemporal patterns of gene expression during fetal monkey brain development.","volume":"146","author":"Redmond","year":"2003","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1177\/1087057106288048_bib24","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pharmthera.2005.07.003","article-title":"Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents.","volume":"109","author":"Lugnier","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1177\/1087057106288048_bib25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1067\/mai.2001.119555","article-title":"Cyclic nucleotide phosphodiesterases.","volume":"108","author":"Essayan","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1177\/1087057106288048_bib26","first-page":"3338","article-title":"Exisulind induction of apoptosis involves guanosine 3\u2032, 5\u2032-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin.","volume":"60","author":"Thompson","year":"2000","journal-title":"Cancer Res"},{"key":"10.1177\/1087057106288048_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bcp.2004.10.009","article-title":"Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.","volume":"69","author":"Tiwari","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1177\/1087057106288048_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/10428190009057627","article-title":"The cAMP signaling pathway as a therapeutic target in lymphoid malignancies.","volume":"37","author":"Lerner","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1177\/1087057106288048_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1568010033344471","article-title":"Regulation of inducible nitric oxide synthase by cAMP-elevating phospho-diesterase inhibitors.","volume":"2","author":"Markovic","year":"2003","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1177\/1087057106288048_bib30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0143-4160(03)00150-7","article-title":"Crosstalk between cAMP and Ca2+ signaling in non-excitable cells.","volume":"34","author":"Bruce","year":"2003","journal-title":"Cell Calcium"},{"key":"10.1177\/1087057106288048_bib31","first-page":"2366","article-title":"Paclitaxel induces apoptosis via protein kinase A- and p38 mitogen-activated protein-dependent inhibition of the Na+\/H+ exchanger (NHE) NHE isoform 1 in human breast cancer cells.","volume":"9","author":"Reshkin","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1177\/1087057106288048_bib32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0962-8924(02)02294-8","article-title":"Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation.","volume":"12","author":"Stork","year":"2002","journal-title":"Trends Cell Biol"},{"key":"10.1177\/1087057106288048_bib33","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1158\/0008-5472.CAN-04-3122","article-title":"8-Chloro-cyclic AMP-induced growth inhibition and apoptosis is mediated by p38 mitogen-activated protein kinase activation in HL60 cells.","volume":"65","author":"Ahn","year":"2005","journal-title":"Cancer Res"},{"key":"10.1177\/1087057106288048_bib34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1042\/bj3470571","article-title":"Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells.","volume":"347","author":"MacKenzie","year":"2000","journal-title":"Biochem J"},{"key":"10.1177\/1087057106288048_bib35","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00001813-200209000-00014","article-title":"Expression and role of phosphodiesterase 3 in human squamous cell carcinoma KB cells.","volume":"13","author":"Shimizu","year":"2002","journal-title":"Anticancer Drugs"},{"key":"10.1177\/1087057106288048_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02737806","article-title":"Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts.","volume":"28","author":"Marko","year":"1998","journal-title":"Cell Biochem Biophys"}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1087057106288048","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247255522208488X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247255522208488X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1087057106288048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T11:31:34Z","timestamp":1762860694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S247255522208488X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S247255522208488X"],"URL":"https:\/\/doi.org\/10.1177\/1087057106288048","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotype-Based Screening of Mechanistically Annotated Compounds in Combination with Gene Expression and Pathway Analysis Identifies Candidate Drug Targets in a Human Squamous Carcinoma Cell Model","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1177\/1087057106288048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Society for Laboratory Automation and Screening. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}